BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Ipca Laboratories Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524494
ISIN Demat
INE571A01038
Book Value (Rs)
291.9817605
NSE Symbol
IPCALAB
Divident Yield %
0.24
Market Cap
(Rs In Cr.)
41,766
P/E (TTM)
41.58
EPS (TTM)
39.59
Face Value
(Rs)
1
Back
Ipca Laboratories consolidated net profit rises 23.13% in the September 2025 quarter
13-Nov-25   Hrs IST

Net profit of Ipca Laboratories rose 23.13% to Rs 282.57 crore in the quarter ended September 2025 as against Rs 229.48 crore during the previous quarter ended September 2024. Sales rose 8.56% to Rs 2556.50 crore in the quarter ended September 2025 as against Rs 2354.90 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales2556.502354.90 9
OPM %21.3218.75 -
PBDT553.17445.18 24
PBT449.84344.83 30
NP282.57229.48 23

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)